PolyPid Other Operating Expenses vs Net Income From Continuing Ops Analysis

PYPD Stock

USD 3.55 0.12 3.50%

PolyPid financial indicator trend analysis is much more than just breaking down PolyPid prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PolyPid is a good investment. Please check the relationship between PolyPid Other Operating Expenses and its Net Income From Continuing Ops accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

Other Operating Expenses vs Net Income From Continuing Ops

Other Operating Expenses vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PolyPid Other Operating Expenses account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between PolyPid's Other Operating Expenses and Net Income From Continuing Ops is -0.59. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of PolyPid, assuming nothing else is changed. The correlation between historical values of PolyPid's Other Operating Expenses and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of PolyPid are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Other Operating Expenses i.e., PolyPid's Other Operating Expenses and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

-0.59

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of PolyPid. It is also known as PolyPid overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Net Income From Continuing Ops

Most indicators from PolyPid's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Enterprise Value is projected to decrease significantly based on the last few years of reporting.

PolyPid fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total
Total Assets		0.59	0.46	0.51	0.58	-0.24	-0.55	0.57	0.49	0.91	0.77	0.77	0.95	-0.52	0.52	0.05	-0.04	0.7	-0.31	0.91	0.59	0.0	0.95	0.53	0.47	0.73
Other Current Liab	0.59		0.77	0.1	0.71	-0.27	-0.67	0.84	0.71	0.52	0.18	0.18	0.55	-0.08	0.69	0.32	0.16	0.75	-0.69	0.76	0.49	0.23	0.56	0.7	0.62	0.67
Total Current Liabilities	0.46	0.77		0.12	0.94	0.21	-0.89	0.65	0.73	0.5	-0.01	-0.01	0.37	-0.45	0.66	0.53	0.04	0.81	-0.46	0.58	0.71	0.12	0.38	0.67	0.84	0.69
Total Stockholder Equity	0.51	0.1	0.12		0.23	0.13	-0.21	0.1	-0.06	0.52	0.51	0.51	0.45	-0.51	0.0	0.11	-0.88	0.21	-0.28	0.45	0.67	-0.86	0.46	0.0	0.19	-0.05
Property Plant And Equipment Net	0.58	0.71	0.94	0.23		0.22	-0.9	0.57	0.67	0.65	0.14	0.15	0.48	-0.53	0.61	0.5	-0.01	0.87	-0.33	0.63	0.75	0.08	0.49	0.62	0.89	0.76
Net Debt	-0.24	-0.27	0.21	0.13	0.22		-0.41	-0.38	-0.29	0.04	-0.15	-0.15	-0.47	-0.61	-0.14	0.67	-0.35	0.16	0.42	-0.26	0.48	-0.3	-0.46	-0.1	0.47	-0.24
Retained Earnings	-0.55	-0.67	-0.89	-0.21	-0.9	-0.41		-0.53	-0.62	-0.62	-0.14	-0.14	-0.37	0.69	-0.6	-0.76	0.03	-0.92	0.26	-0.59	-0.85	-0.07	-0.38	-0.63	-0.98	-0.69
Accounts Payable	0.57	0.84	0.65	0.1	0.57	-0.38	-0.53		0.63	0.33	0.01	0.02	0.63	0.05	0.54	0.14	0.16	0.61	-0.82	0.69	0.4	0.22	0.63	0.55	0.46	0.64
Cash	0.49	0.71	0.73	-0.06	0.67	-0.29	-0.62	0.63		0.37	0.0	0.0	0.49	-0.21	0.63	0.25	0.3	0.67	-0.44	0.57	0.37	0.36	0.49	0.64	0.58	0.83
Non Current Assets Total	0.91	0.52	0.5	0.52	0.65	0.04	-0.62	0.33	0.37		0.84	0.84	0.78	-0.68	0.47	0.18	-0.11	0.69	-0.12	0.85	0.66	-0.06	0.79	0.48	0.56	0.61
Non Currrent Assets Other	0.77	0.18	-0.01	0.51	0.14	-0.15	-0.14	0.01	0.0	0.84		1.0	0.69	-0.48	0.19	-0.18	-0.12	0.25	0.08	0.65	0.29	-0.13	0.69	0.19	0.06	0.27
Other Assets	0.77	0.18	-0.01	0.51	0.15	-0.15	-0.14	0.02	0.0	0.84	1.0		0.69	-0.48	0.19	-0.18	-0.13	0.26	0.07	0.66	0.3	-0.13	0.7	0.19	0.06	0.27
Cash And Short Term Investments	0.95	0.55	0.37	0.45	0.48	-0.47	-0.37	0.63	0.49	0.78	0.69	0.69		-0.31	0.51	-0.17	0.02	0.57	-0.4	0.84	0.41	0.04	1.0	0.51	0.28	0.72
Net Receivables	-0.52	-0.08	-0.45	-0.51	-0.53	-0.61	0.69	0.05	-0.21	-0.68	-0.48	-0.48	-0.31		-0.2	-0.55	0.37	-0.55	-0.19	-0.41	-0.79	0.3	-0.32	-0.23	-0.65	-0.34
Common Stock Total Equity	0.52	0.69	0.66	0.0	0.61	-0.14	-0.6	0.54	0.63	0.47	0.19	0.19	0.51	-0.2		0.24	0.26	0.77	-0.15	0.43	0.38	0.31	0.51	1.0	0.51	0.74
Common Stock Shares Outstanding	0.05	0.32	0.53	0.11	0.5	0.67	-0.76	0.14	0.25	0.18	-0.18	-0.18	-0.17	-0.55	0.24		-0.22	0.59	-0.05	0.08	0.69	-0.12	-0.16	0.29	0.81	0.2
Non Current Liabilities Total	-0.04	0.16	0.04	-0.88	-0.01	-0.35	0.03	0.16	0.3	-0.11	-0.12	-0.13	0.02	0.37	0.26	-0.22		0.07	0.17	-0.04	-0.53	0.99	0.01	0.25	-0.06	0.43
Capital Surpluse	0.7	0.75	0.81	0.21	0.87	0.16	-0.92	0.61	0.67	0.69	0.25	0.26	0.57	-0.55	0.77	0.59	0.07		-0.23	0.64	0.75	0.17	0.57	0.8	0.9	0.83
Inventory	-0.31	-0.69	-0.46	-0.28	-0.33	0.42	0.26	-0.82	-0.44	-0.12	0.08	0.07	-0.4	-0.19	-0.15	-0.05	0.17	-0.23		-0.58	-0.31	0.14	-0.41	-0.14	-0.21	-0.23
Other Current Assets	0.91	0.76	0.58	0.45	0.63	-0.26	-0.59	0.69	0.57	0.85	0.65	0.66	0.84	-0.41	0.43	0.08	-0.04	0.64	-0.58		0.6	0.01	0.86	0.44	0.5	0.64
Other Stockholder Equity	0.59	0.49	0.71	0.67	0.75	0.48	-0.85	0.4	0.37	0.66	0.29	0.3	0.41	-0.79	0.38	0.69	-0.53	0.75	-0.31	0.6		-0.44	0.42	0.41	0.84	0.41
Total Liab	0.0	0.23	0.12	-0.86	0.08	-0.3	-0.07	0.22	0.36	-0.06	-0.13	-0.13	0.04	0.3	0.31	-0.12	0.99	0.17	0.14	0.01	-0.44		0.03	0.31	0.04	0.49
Total Current Assets	0.95	0.56	0.38	0.46	0.49	-0.46	-0.38	0.63	0.49	0.79	0.69	0.7	1.0	-0.32	0.51	-0.16	0.01	0.57	-0.41	0.86	0.42	0.03		0.5	0.29	0.72
Common Stock	0.53	0.7	0.67	0.0	0.62	-0.1	-0.63	0.55	0.64	0.48	0.19	0.19	0.51	-0.23	1.0	0.29	0.25	0.8	-0.14	0.44	0.41	0.31	0.5		0.55	0.74
Property Plant Equipment	0.47	0.62	0.84	0.19	0.89	0.47	-0.98	0.46	0.58	0.56	0.06	0.06	0.28	-0.65	0.51	0.81	-0.06	0.9	-0.21	0.5	0.84	0.04	0.29	0.55		0.64
Short Long Term Debt Total	0.73	0.67	0.69	-0.05	0.76	-0.24	-0.69	0.64	0.83	0.61	0.27	0.27	0.72	-0.34	0.74	0.2	0.43	0.83	-0.23	0.64	0.41	0.49	0.72	0.74	0.64

Click cells to compare fundamentals

PolyPid Account Relationship Matchups

PolyPid fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.8M	75.8M	44.2M	26.0M	15.4M	25.8M
Other Current Liab	998K	1.9M	3.9M	1.5M	2.0M	1.7M
Total Current Liabilities	2.6M	2.9M	7.8M	8.6M	7.3M	4.0M
Total Stockholder Equity	30.9M	72.8M	36.2M	5.9M	(2.1M)	(2.2M)
Property Plant And Equipment Net	6.1M	5.9M	8.8M	11.7M	9.2M	5.3M
Net Debt	(3.9M)	(4.3M)	(9.8M)	5.2M	6.2M	6.5M
Retained Earnings	(93.3M)	(132.3M)	(174.6M)	(214.4M)	(238.3M)	(226.4M)
Accounts Payable	1.6M	974K	4.1M	1.1M	772K	1.3M
Cash	3.9M	4.3M	9.8M	8.6M	5.6M	5.8M
Non Current Assets Total	6.4M	28.3M	9.4M	11.8M	9.3M	7.8M
Non Currrent Assets Other	31K	22.2M	423K	99K	87K	82.7K
Other Assets	230K	22.8M	663K	99K	113.9K	108.2K
Cash And Short Term Investments	26.6M	44.5M	32.2M	12.6M	5.6M	5.3M
Net Receivables	42K	(251K)	118K	(213K)	(191.7K)	(182.1K)
Liabilities And Stockholders Equity	33.8M	75.8M	44.2M	26.0M	15.4M	25.8M
Non Current Liabilities Total	251K	193K	199K	11.5M	10.2M	9.7M
Other Current Assets	399K	2.3M	2.2M	1.1M	458K	878.4K
Other Stockholder Equity	124.2M	205.1M	210.8M	220.3M	236.2M	248.0M
Total Liab	2.8M	3.1M	8.0M	20.1M	17.5M	24.1M
Total Current Assets	27.4M	47.6M	34.8M	14.2M	6.1M	5.8M
Accumulated Other Comprehensive Income	(766K)	(1.2M)	(106.4M)	(3.1M)	(2.8M)	(3.0M)
Property Plant Equipment	6.1M	5.9M	8.8M	11.7M	13.4M	14.1M
Other Liab	251K	193K	199K	2.8M	3.3M	3.4M
Net Tangible Assets	(87.6M)	72.8M	36.2M	5.8M	6.7M	7.0M
Short Term Investments	14.0M	0.0	22.7M	40.2M	22.4M	4.0M
Non Current Liabilities Other	251K	193K	199K	174K	398K	273.2K
Net Invested Capital	30.9M	72.8M	36.2M	17.5M	8.3M	8.7M
Net Working Capital	24.8M	44.3M	27.0M	5.6M	(1.2M)	(1.2M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:

How To Invest In PolyPid

Details

Is PolyPid Stock a good investment?

Details

What is PolyPid's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(7.22)

Return On Assets

(0.65)

Return On Equity

(4.97)

The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PolyPid Other Operating Expenses vs Net Income From Continuing Ops Analysis

Other Operating Expenses vs Net Income From Continuing Ops

Other Operating Expenses vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Other Operating Expenses

Net Income From Continuing Ops

PolyPid fundamental ratios Correlations

PolyPid Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PolyPid fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Assets	+ 1.0	Non Currrent Assets Other
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Total Liab	+ 0.99	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.95	Total Assets
Total Current Assets	+ 0.95	Total Assets

Property Plant Equipment	- 0.98	Retained Earnings
Capital Surpluse	- 0.92	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Retained Earnings	- 0.89	Total Current Liabilities
Non Current Liabilities Total	- 0.88	Total Stockholder Equity
Total Liab	- 0.86	Total Stockholder Equity